Correlation Between Dr Reddys and Teva Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dr Reddys and Teva Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and Teva Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dr Reddys Laboratories and Teva Pharmaceutical Industries, you can compare the effects of market volatilities on Dr Reddys and Teva Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of Teva Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and Teva Pharmaceutical.

Diversification Opportunities for Dr Reddys and Teva Pharmaceutical

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between RDDA and Teva is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and Teva Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharmaceutical and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with Teva Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharmaceutical has no effect on the direction of Dr Reddys i.e., Dr Reddys and Teva Pharmaceutical go up and down completely randomly.

Pair Corralation between Dr Reddys and Teva Pharmaceutical

Assuming the 90 days trading horizon Dr Reddys is expected to generate 3.07 times less return on investment than Teva Pharmaceutical. But when comparing it to its historical volatility, Dr Reddys Laboratories is 2.1 times less risky than Teva Pharmaceutical. It trades about 0.07 of its potential returns per unit of risk. Teva Pharmaceutical Industries is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  1,495  in Teva Pharmaceutical Industries on September 26, 2024 and sell it today you would earn a total of  605.00  from holding Teva Pharmaceutical Industries or generate 40.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Dr Reddys Laboratories  vs.  Teva Pharmaceutical Industries

 Performance 
       Timeline  
Dr Reddys Laboratories 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Teva Pharmaceutical 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Teva Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Dr Reddys and Teva Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dr Reddys and Teva Pharmaceutical

The main advantage of trading using opposite Dr Reddys and Teva Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, Teva Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharmaceutical will offset losses from the drop in Teva Pharmaceutical's long position.
The idea behind Dr Reddys Laboratories and Teva Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios